Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)

Treatment of chronic nephropathies using soluble complement receptor type I (sCR1)

US Patent 9295713 · Granted Mar 29, 2016

Estimated economic value: $7,524,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recommendation model training method and related apparatus2025
Determining medical staffing for oral immunotherapy2025
Algorithm and architecture for channel estimation in 5G new radio2024
Carrier frequency offset correction and doppler mitigation2023
Recommendation method and apparatus2023
Chimeric antigen receptors targeting TIM-12023
Antibodies that bind human CD27 and uses thereof2021
High speed turbo decoder2018
Methods to prevent and treat autosomal dominant non-syndromic hearing loss2017
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2017
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2017
Treatment of chronic nephropathies using soluble complement receptor type I (sCR2017